Callie is the CEO and founder of Eunoe, an immersive self-discovery and resilience platform, empowering individuals and organizations to holistically overcome burnout and other barriers to mental wellbeing. She leads a multi-disciplinary and passionate team weaving evidence-based practices from psychology, neuroscience, gaming, and storytelling to guide people believe in themselves and forge their own towards wellness by helping them reframe negative thoughts using the power of their own voice.

She was a member of the 2018 Oculus Launchpad cohort and has been active in the XR community since 2014. Callie has launched and operated innovation studios, accelerators, and coworking spaces, and hackathons for organizations that include the United States Department of Defense, NYU, Amazon, and the Tri-Institutional Program at Weill Cornell Medicine, The Rockefeller University, and Memorial Sloan Kettering Cancer Center, and Galvanize in New York City. Callie also has experience in the venture world, having supported 100+ early-stage digital health entrepreneurs in scaling their companies throughout the health and wellness ecosystem.

Callie serves as an advisor on the XRSI Medical Council which is committed to building the strategies and resources necessary to help healthcare solution providers, health delivery organizations, and regulators organizations leverage XR to be more successful. The council collaborates with agencies like FDA, WHO, CDC, and other industry advisory councils to further study the implications XR adoption within the medical ecosystems. 

She also serves on the Young Professionals Committee as the Science Co-Chair at the Alzheimers Drug Discovery Foundation. The ADDF is dedicated to rapidly accelerate the discovery of drugs to prevent, treat and cure Alzheimer's disease.